<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-11-01" modified="2018-01-31" version="219">
<accession>P04049</accession>
<accession>B0LPH8</accession>
<accession>B2R5N3</accession>
<accession>Q15278</accession>
<accession>Q9UC20</accession>
<name>RAF1_HUMAN</name>
<protein>
<recommendedName>
<fullName>RAF proto-oncogene serine/threonine-protein kinase</fullName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Proto-oncogene c-RAF</fullName>
<shortName>cRaf</shortName>
</alternativeName>
<alternativeName>
<fullName>Raf-1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">RAF1</name>
<name type="synonym">RAF</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Nucleic Acids Res." volume="14" first="1009" last="1015">
<title>The complete coding sequence of the human raf oncogene and the corresponding structure of the c-raf-1 gene.</title>
<authorList>
<person name="Bonner T.I."/>
<person name="Oppermann H."/>
<person name="Seeburg P."/>
<person name="Kerby S.B."/>
<person name="Gunnell M.A."/>
<person name="Young A.C."/>
<person name="Rapp U.R."/>
</authorList>
<dbReference type="PubMed" id="3003687"/>
<dbReference type="DOI" id="10.1093/nar/14.2.1009"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT LEU-308</scope>
</reference>
<reference key="3">
<citation type="submission" date="2007-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT LEU-308</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1985" name="Mol. Cell. Biol." volume="5" first="1400" last="1407">
<title>Structure and biological activity of human homologs of the raf/mil oncogene.</title>
<authorList>
<person name="Bonner T.I."/>
<person name="Kerby S.B."/>
<person name="Sutrave P."/>
<person name="Gunnell M.A."/>
<person name="Mark G."/>
<person name="Rapp U.R."/>
</authorList>
<dbReference type="PubMed" id="2993863"/>
<dbReference type="DOI" id="10.1128/MCB.5.6.1400"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 228-648</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RA58" last="RA58">
<title>Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF.</title>
<authorList>
<person name="Andreu-Perez P."/>
<person name="Esteve-Puig R."/>
<person name="de Torre-Minguela C."/>
<person name="Lopez-Fauqued M."/>
<person name="Bech-Serra J.J."/>
<person name="Tenbaum S."/>
<person name="Garcia-Trevijano E.R."/>
<person name="Canals F."/>
<person name="Merlino G."/>
<person name="Avila M.A."/>
<person name="Recio J.A."/>
</authorList>
<dbReference type="PubMed" id="21917714"/>
<dbReference type="DOI" id="10.1126/scisignal.2001936"/>
</citation>
<scope>PROTEIN SEQUENCE OF 42-53; 60-65; 310-316 AND 564-572</scope>
<scope>INTERACTION WITH PRMT5</scope>
<scope>METHYLATION AT ARG-563</scope>
<scope>PHOSPHORYLATION AT SER-289; SER-296; SER-301; SER-338 AND SER-621</scope>
<scope>MUTAGENESIS OF ARG-563</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1995" name="Nature" volume="378" first="307" last="310">
<title>Phosphorylation of Raf by ceramide-activated protein kinase.</title>
<authorList>
<person name="Yao B."/>
<person name="Zhang Y."/>
<person name="Delikat S."/>
<person name="Mathias S."/>
<person name="Basu S."/>
<person name="Kolesnick R."/>
</authorList>
<dbReference type="PubMed" id="7477354"/>
<dbReference type="DOI" id="10.1038/378307a0"/>
</citation>
<scope>PROTEIN SEQUENCE OF 254-278</scope>
<scope>PHOSPHORYLATION AT THR-269</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1991" name="Oncogene" volume="6" first="1307" last="1311">
<title>An alternatively spliced c-mil/raf mRNA is predominantly expressed in chicken muscular tissues and conserved among vertebrate species.</title>
<authorList>
<person name="Dozier C."/>
<person name="Ansieau S."/>
<person name="Ferreira E."/>
<person name="Coll J."/>
<person name="Stehelin D."/>
</authorList>
<dbReference type="PubMed" id="1886707"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="17309" last="17316">
<title>Identification of the major phosphorylation sites of the Raf-1 kinase.</title>
<authorList>
<person name="Morrison D.K."/>
<person name="Heidecker G."/>
<person name="Rapp U.R."/>
<person name="Copeland T.D."/>
</authorList>
<dbReference type="PubMed" id="8349614"/>
</citation>
<scope>PHOSPHORYLATION AT SER-43; SER-259; THR-268; SER-499 AND SER-621</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="28882" last="28888">
<title>14-3-3 is phosphorylated by casein kinase I on residue 233. Phosphorylation at this site in vivo regulates Raf/14-3-3 interaction.</title>
<authorList>
<person name="Dubois T."/>
<person name="Rommel C."/>
<person name="Howell S."/>
<person name="Steinhussen U."/>
<person name="Soneji Y."/>
<person name="Morrice N."/>
<person name="Moelling K."/>
<person name="Aitken A."/>
</authorList>
<dbReference type="PubMed" id="9360956"/>
<dbReference type="DOI" id="10.1074/jbc.272.46.28882"/>
</citation>
<scope>INTERACTION WITH YWHAZ</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="Nature" volume="396" first="180" last="183">
<title>The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338.</title>
<authorList>
<person name="King A.J."/>
<person name="Sun H."/>
<person name="Diaz B."/>
<person name="Barnard D."/>
<person name="Miao W."/>
<person name="Bagrodia S."/>
<person name="Marshall M.S."/>
</authorList>
<dbReference type="PubMed" id="9823899"/>
<dbReference type="DOI" id="10.1038/24184"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Nature" volume="406" first="439" last="439">
<authorList>
<person name="King A.J."/>
<person name="Sun H."/>
<person name="Diaz B."/>
<person name="Barnard D."/>
<person name="Miao W."/>
<person name="Bagrodia S."/>
<person name="Marshall M.S."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Science" volume="286" first="1741" last="1744">
<title>Phosphorylation and regulation of Raf by Akt (protein kinase B).</title>
<authorList>
<person name="Zimmermann S."/>
<person name="Moelling K."/>
</authorList>
<dbReference type="PubMed" id="10576742"/>
<dbReference type="DOI" id="10.1126/science.286.5445.1741"/>
</citation>
<scope>PHOSPHORYLATION AT SER-259 BY PKB/AKT1</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH PKB/AKT1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="22300" last="22304">
<title>Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation.</title>
<authorList>
<person name="Abraham D."/>
<person name="Podar K."/>
<person name="Pacher M."/>
<person name="Kubicek M."/>
<person name="Welzel N."/>
<person name="Hemmings B.A."/>
<person name="Dilworth S.M."/>
<person name="Mischak H."/>
<person name="Kolch W."/>
<person name="Baccarini M."/>
</authorList>
<dbReference type="PubMed" id="10801873"/>
<dbReference type="DOI" id="10.1074/jbc.M003259200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-259 AND SER-621</scope>
<scope>DEPHOSPHORYLATION AT SER-43; SER-259 AND SER-621</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH PPP2CA AND PPP2R1B</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="3716" last="3727">
<title>Positive and negative regulation of Raf kinase activity and function by phosphorylation.</title>
<authorList>
<person name="Chong H."/>
<person name="Lee J."/>
<person name="Guan K.L."/>
</authorList>
<dbReference type="PubMed" id="11447113"/>
<dbReference type="DOI" id="10.1093/emboj/20.14.3716"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION AT THR-491 AND SER-494</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="7783" last="7788">
<title>Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism.</title>
<authorList>
<person name="Chen J."/>
<person name="Fujii K."/>
<person name="Zhang L."/>
<person name="Roberts T."/>
<person name="Fu H."/>
</authorList>
<dbReference type="PubMed" id="11427728"/>
<dbReference type="DOI" id="10.1073/pnas.141224398"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MAP3K5/ASK1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="3053" last="3059">
<title>Phosphorylation of the myosin-binding subunit of myosin phosphatase by Raf-1 and inhibition of phosphatase activity.</title>
<authorList>
<person name="Broustas C.G."/>
<person name="Grammatikakis N."/>
<person name="Eto M."/>
<person name="Dent P."/>
<person name="Brautigan D.L."/>
<person name="Kasid U."/>
</authorList>
<dbReference type="PubMed" id="11719507"/>
<dbReference type="DOI" id="10.1074/jbc.M106343200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PPP1R12A</scope>
<scope>INTERACTION WITH PPP1R12A</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="4395" last="4405">
<title>Interaction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1.</title>
<authorList>
<person name="Zang M."/>
<person name="Hayne C."/>
<person name="Luo Z."/>
</authorList>
<dbReference type="PubMed" id="11733498"/>
<dbReference type="DOI" id="10.1074/jbc.M110000200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-338 BY PAK1</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH PAK1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="7913" last="7919">
<title>Dephosphorylation of Ser-259 regulates Raf-1 membrane association.</title>
<authorList>
<person name="Kubicek M."/>
<person name="Pacher M."/>
<person name="Abraham D."/>
<person name="Podar K."/>
<person name="Eulitz M."/>
<person name="Baccarini M."/>
</authorList>
<dbReference type="PubMed" id="11756411"/>
<dbReference type="DOI" id="10.1074/jbc.M108733200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-259</scope>
<scope>DEPHOSPHORYLATION AT SER-259</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="916" last="926">
<title>The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins.</title>
<authorList>
<person name="Wang Y."/>
<person name="Waldron R.T."/>
<person name="Dhaka A."/>
<person name="Patel A."/>
<person name="Riley M.M."/>
<person name="Rozengurt E."/>
<person name="Colicelli J."/>
</authorList>
<dbReference type="PubMed" id="11784866"/>
<dbReference type="DOI" id="10.1128/MCB.22.13.4638-4651.2002"/>
</citation>
<scope>COMPETITION WITH RIN1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="Nat. Cell Biol." volume="5" first="427" last="432">
<title>Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.</title>
<authorList>
<person name="Sasaki A."/>
<person name="Taketomi T."/>
<person name="Kato R."/>
<person name="Saeki K."/>
<person name="Nonami A."/>
<person name="Sasaki M."/>
<person name="Kuriyama M."/>
<person name="Saito N."/>
<person name="Shibuya M."/>
<person name="Yoshimura A."/>
</authorList>
<dbReference type="PubMed" id="12717443"/>
<dbReference type="DOI" id="10.1038/ncb978"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH SPRY2 AND SPRY4</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="23151" last="23157">
<title>LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway.</title>
<authorList>
<person name="Kunapuli P."/>
<person name="Kasyapa C.S."/>
<person name="Hawthorn L."/>
<person name="Cowell J.K."/>
</authorList>
<dbReference type="PubMed" id="15047712"/>
<dbReference type="DOI" id="10.1074/jbc.M314192200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-259</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="2752" last="2752">
<authorList>
<person name="Kunapuli P."/>
<person name="Kasyapa C.S."/>
<person name="Hawthorn L."/>
<person name="Cowell J.K."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="Mol. Pharmacol." volume="66" first="921" last="928">
<title>Raf kinase activation of adenylyl cyclases: isoform-selective regulation.</title>
<authorList>
<person name="Ding Q."/>
<person name="Gros R."/>
<person name="Gray I.D."/>
<person name="Taussig R."/>
<person name="Ferguson S.S."/>
<person name="Feldman R.D."/>
</authorList>
<dbReference type="PubMed" id="15385642"/>
<dbReference type="DOI" id="10.1124/mol.66.4."/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF ADCY2; ADCY5 AND ADCY6</scope>
<scope>INTERACTION WITH ADCY2; ADCY5 AND ADCY6</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="Science" volume="306" first="2267" last="2270">
<title>Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1.</title>
<authorList>
<person name="O'Neill E."/>
<person name="Rushworth L."/>
<person name="Baccarini M."/>
<person name="Kolch W."/>
</authorList>
<dbReference type="PubMed" id="15618521"/>
<dbReference type="DOI" id="10.1126/science.1103233"/>
</citation>
<scope>INTERACTION WITH STK3/MST2</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="Arch. Biochem. Biophys." volume="439" first="121" last="128">
<title>Raf-1 is a binding partner of DSCR1.</title>
<authorList>
<person name="Cho Y.J."/>
<person name="Abe M."/>
<person name="Kim S.Y."/>
<person name="Sato Y."/>
</authorList>
<dbReference type="PubMed" id="15935327"/>
<dbReference type="DOI" id="10.1016/j.abb.2005.05.002"/>
</citation>
<scope>INTERACTION WITH RCAN1/DSCR1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="FEBS Lett." volume="579" first="3271" last="3277">
<title>Second nature: biological functions of the Raf-1 'kinase'.</title>
<authorList>
<person name="Baccarini M."/>
</authorList>
<dbReference type="PubMed" id="15943972"/>
<dbReference type="DOI" id="10.1016/j.febslet.2005.03.024"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="24698" last="24705">
<title>p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association.</title>
<authorList>
<person name="Jin S."/>
<person name="Zhuo Y."/>
<person name="Guo W."/>
<person name="Field J."/>
</authorList>
<dbReference type="PubMed" id="15849194"/>
<dbReference type="DOI" id="10.1074/jbc.M413374200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF BAD</scope>
<scope>PHOSPHORYLATION AT SER-338 AND SER-339 BY PAK1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH BCL2</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2005" name="Mol. Biol. Cell" volume="16" first="4733" last="4744">
<title>Identification of Raf-1 S471 as a novel phosphorylation site critical for Raf-1 and B-Raf kinase activities and for MEK binding.</title>
<authorList>
<person name="Zhu J."/>
<person name="Balan V."/>
<person name="Bronisz A."/>
<person name="Balan K."/>
<person name="Sun H."/>
<person name="Leicht D.T."/>
<person name="Luo Z."/>
<person name="Qin J."/>
<person name="Avruch J."/>
<person name="Tzivion G."/>
</authorList>
<dbReference type="PubMed" id="16093354"/>
<dbReference type="DOI" id="10.1091/mbc.E05-02-0090"/>
</citation>
<scope>PHOSPHORYLATION AT SER-471</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Mol. Cell" volume="22" first="217" last="230">
<title>A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity.</title>
<authorList>
<person name="Rodriguez-Viciana P."/>
<person name="Oses-Prieto J."/>
<person name="Burlingame A."/>
<person name="Fried M."/>
<person name="McCormick F."/>
</authorList>
<dbReference type="PubMed" id="16630891"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.03.027"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH PP1CA; PPP1CB; PPP1CC; SHOC2 AND MRAS</scope>
<scope>PHOSPHORYLATION AT SER-259</scope>
<scope>CHARACTERIZATION OF VARIANT ALA-259</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="2262" last="2272">
<title>Regulation and role of Raf-1/B-Raf heterodimerization.</title>
<authorList>
<person name="Rushworth L.K."/>
<person name="Hindley A.D."/>
<person name="O'Neill E."/>
<person name="Kolch W."/>
</authorList>
<dbReference type="PubMed" id="16508002"/>
<dbReference type="DOI" id="10.1128/MCB.26.6.2262-2272.2006"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="1011" last="1016">
<title>Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5.</title>
<authorList>
<person name="von Kriegsheim A."/>
<person name="Pitt A."/>
<person name="Grindlay G.J."/>
<person name="Kolch W."/>
<person name="Dhillon A.S."/>
</authorList>
<dbReference type="PubMed" id="16892053"/>
<dbReference type="DOI" id="10.1038/ncb1465"/>
</citation>
<scope>FUNCTION AS KINASE</scope>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION AT SER-259; SER-338; TYR-340; TYR-341 AND SER-621</scope>
<scope>DEPHOSPHORYLATION AT SER-338 BY PPP5C</scope>
<scope>MUTAGENESIS OF 338-SER-SER-339; 340-TYR-TYR-341; THR-491 AND SER-494</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="Cell Cycle" volume="6" first="3" last="7">
<title>Phosphatase and feedback regulation of Raf-1 signaling.</title>
<authorList>
<person name="Dhillon A.S."/>
<person name="von Kriegsheim A."/>
<person name="Grindlay J."/>
<person name="Kolch W."/>
</authorList>
<dbReference type="PubMed" id="17218791"/>
<dbReference type="DOI" id="10.4161/cc.6.1.3593"/>
</citation>
<scope>REVIEW ON REGULATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="1222" last="1230">
<title>Raf 1 represses expression of the tight junction protein occludin via activation of the zinc-finger transcription factor slug.</title>
<authorList>
<person name="Wang Z."/>
<person name="Wade P."/>
<person name="Mandell K.J."/>
<person name="Akyildiz A."/>
<person name="Parkos C.A."/>
<person name="Mrsny R.J."/>
<person name="Nusrat A."/>
</authorList>
<dbReference type="PubMed" id="16924233"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209902"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2008" name="Cell. Signal." volume="20" first="935" last="941">
<title>The RKIP (Raf-1 Kinase Inhibitor Protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK.</title>
<authorList>
<person name="Rath O."/>
<person name="Park S."/>
<person name="Tang H.H."/>
<person name="Banfield M.J."/>
<person name="Brady R.L."/>
<person name="Lee Y.C."/>
<person name="Dignam J.D."/>
<person name="Sedivy J.M."/>
<person name="Kolch W."/>
<person name="Yeung K.C."/>
</authorList>
<dbReference type="PubMed" id="18294816"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2008.01.012"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH PEBP1/RKIP</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="J. Cell. Biochem." volume="105" first="167" last="175">
<title>p21 activated kinase 5 activates Raf-1 and targets it to mitochondria.</title>
<authorList>
<person name="Wu X."/>
<person name="Carr H.S."/>
<person name="Dan I."/>
<person name="Ruvolo P.P."/>
<person name="Frost J.A."/>
</authorList>
<dbReference type="PubMed" id="18465753"/>
<dbReference type="DOI" id="10.1002/jcb.21809"/>
</citation>
<scope>PHOSPHORYLATION AT SER-338 BY PAK5</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-642</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2009" name="Exp. Cell Res." volume="315" first="2241" last="2248">
<title>Retinoic acid induces nuclear accumulation of Raf1 during differentiation of HL-60 cells.</title>
<authorList>
<person name="Smith J."/>
<person name="Bunaciu R.P."/>
<person name="Reiterer G."/>
<person name="Coder D."/>
<person name="George T."/>
<person name="Asaly M."/>
<person name="Yen A."/>
</authorList>
<dbReference type="PubMed" id="19298812"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2009.03.004"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="29559" last="29570">
<title>Diacylglycerol kinase eta augments C-Raf activity and B-Raf/C-Raf heterodimerization.</title>
<authorList>
<person name="Yasuda S."/>
<person name="Kai M."/>
<person name="Imai S."/>
<person name="Takeishi K."/>
<person name="Taketomi A."/>
<person name="Toyota M."/>
<person name="Kanoh H."/>
<person name="Sakane F."/>
</authorList>
<dbReference type="PubMed" id="19710016"/>
<dbReference type="DOI" id="10.1074/jbc.M109.043604"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH DGKH</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289 AND SER-301</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="399" first="313" last="317">
<title>RAF protein-serine/threonine kinases: structure and regulation.</title>
<authorList>
<person name="Roskoski R. Jr."/>
</authorList>
<dbReference type="PubMed" id="20674547"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.07.092"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="47">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2011" name="Genes Cancer" volume="2" first="232" last="260">
<title>Raf family kinases: old dogs have learned new tricks.</title>
<authorList>
<person name="Matallanas D."/>
<person name="Birtwistle M."/>
<person name="Romano D."/>
<person name="Zebisch A."/>
<person name="Rauch J."/>
<person name="von Kriegsheim A."/>
<person name="Kolch W."/>
</authorList>
<dbReference type="PubMed" id="21779496"/>
<dbReference type="DOI" id="10.1177/1947601911407323"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2012" name="J. Clin. Invest." volume="122" first="3197" last="3210">
<title>FAM83B mediates EGFR- and RAS-driven oncogenic transformation.</title>
<authorList>
<person name="Cipriano R."/>
<person name="Graham J."/>
<person name="Miskimen K.L."/>
<person name="Bryson B.L."/>
<person name="Bruntz R.C."/>
<person name="Scott S.A."/>
<person name="Brown H.A."/>
<person name="Stark G.R."/>
<person name="Jackson M.W."/>
</authorList>
<dbReference type="PubMed" id="22886302"/>
<dbReference type="DOI" id="10.1172/JCI60517"/>
</citation>
<scope>INTERACTION WITH FAM83B</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296; SER-301 AND SER-642</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="52">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="E1533" last="E1542">
<title>Phosphodiesterase-8A binds to and regulates Raf-1 kinase.</title>
<authorList>
<person name="Brown K.M."/>
<person name="Day J.P."/>
<person name="Huston E."/>
<person name="Zimmermann B."/>
<person name="Hampel K."/>
<person name="Christian F."/>
<person name="Romano D."/>
<person name="Terhzaz S."/>
<person name="Lee L.C."/>
<person name="Willis M.J."/>
<person name="Morton D.B."/>
<person name="Beavo J.A."/>
<person name="Shimizu-Albergine M."/>
<person name="Davies S.A."/>
<person name="Kolch W."/>
<person name="Houslay M.D."/>
<person name="Baillie G.S."/>
</authorList>
<dbReference type="PubMed" id="23509299"/>
<dbReference type="DOI" id="10.1073/pnas.1303004110"/>
</citation>
<scope>INTERACTION WITH PDE8A</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="54">
<citation type="journal article" date="1995" name="Nature" volume="375" first="554" last="560">
<title>The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue.</title>
<authorList>
<person name="Nassar N."/>
<person name="Horn G."/>
<person name="Herrmann C."/>
<person name="Scherer A."/>
<person name="McCormick F."/>
<person name="Wittinghofer A."/>
</authorList>
<dbReference type="PubMed" id="7791872"/>
<dbReference type="DOI" id="10.1038/375554a0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 51-131</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1996" name="Nat. Struct. Biol." volume="3" first="723" last="729">
<title>Ras/Rap effector specificity determined by charge reversal.</title>
<authorList>
<person name="Nassar N."/>
<person name="Horn G."/>
<person name="Herrmann C."/>
<person name="Block C."/>
<person name="Janknecht R."/>
<person name="Wittinghofer A."/>
</authorList>
<dbReference type="PubMed" id="8756332"/>
<dbReference type="DOI" id="10.1038/nsb0896-723"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 56-131</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1995" name="Biochemistry" volume="34" first="6911" last="6918">
<title>Solution structure of the Ras-binding domain of c-Raf-1 and identification of its Ras interaction surface.</title>
<authorList>
<person name="Emerson S.D."/>
<person name="Madison V.S."/>
<person name="Palermo R.E."/>
<person name="Waugh D.S."/>
<person name="Scheffler J.E."/>
<person name="Tsao K.L."/>
<person name="Kiefer S.E."/>
<person name="Liu S.P."/>
<person name="Fry D.C."/>
</authorList>
<dbReference type="PubMed" id="7766599"/>
<dbReference type="DOI" id="10.1021/bi00021a001"/>
</citation>
<scope>STRUCTURE BY NMR OF 55-132</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="8312" last="8317">
<title>The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site.</title>
<authorList>
<person name="Mott H.R."/>
<person name="Carpenter J.W."/>
<person name="Zhong S."/>
<person name="Ghosh S."/>
<person name="Bell R.M."/>
<person name="Campbell S.L."/>
</authorList>
<dbReference type="PubMed" id="8710867"/>
<dbReference type="DOI" id="10.1073/pnas.93.16.8312"/>
</citation>
<scope>STRUCTURE BY NMR OF 136-187</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2007" name="Nat. Genet." volume="39" first="1007" last="1012">
<title>Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.</title>
<authorList>
<person name="Pandit B."/>
<person name="Sarkozy A."/>
<person name="Pennacchio L.A."/>
<person name="Carta C."/>
<person name="Oishi K."/>
<person name="Martinelli S."/>
<person name="Pogna E.A."/>
<person name="Schackwitz W."/>
<person name="Ustaszewska A."/>
<person name="Landstrom A."/>
<person name="Bos J.M."/>
<person name="Ommen S.R."/>
<person name="Esposito G."/>
<person name="Lepri F."/>
<person name="Faul C."/>
<person name="Mundel P."/>
<person name="Lopez Siguero J.P."/>
<person name="Tenconi R."/>
<person name="Selicorni A."/>
<person name="Rossi C."/>
<person name="Mazzanti L."/>
<person name="Torrente I."/>
<person name="Marino B."/>
<person name="Digilio M.C."/>
<person name="Zampino G."/>
<person name="Ackerman M.J."/>
<person name="Dallapiccola B."/>
<person name="Tartaglia M."/>
<person name="Gelb B.D."/>
</authorList>
<dbReference type="PubMed" id="17603483"/>
<dbReference type="DOI" id="10.1038/ng2073"/>
</citation>
<scope>VARIANTS NS5 SER-256; PHE-259; ARG-260; LEU-261; SER-261; ASN-486; GLY-486; ILE-491; ARG-491 AND THR-612</scope>
<scope>VARIANT HYPERTROPHIC CARDIOMYOPATHY ILE-260</scope>
<scope>VARIANTS LPRD2 LEU-257 AND VAL-613</scope>
<scope>VARIANT NS5 LEU-257</scope>
<scope>CHARACTERIZATION OF VARIANTS NS5 SER-261; ASN-486 AND ILE-491</scope>
<scope>CHARACTERIZATION OF VARIANT LPRD2 VAL-613</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2007" name="Nat. Genet." volume="39" first="1013" last="1017">
<title>Germline gain-of-function mutations in RAF1 cause Noonan syndrome.</title>
<authorList>
<person name="Razzaque M.A."/>
<person name="Nishizawa T."/>
<person name="Komoike Y."/>
<person name="Yagi H."/>
<person name="Furutani M."/>
<person name="Amo R."/>
<person name="Kamisago M."/>
<person name="Momma K."/>
<person name="Katayama H."/>
<person name="Nakagawa M."/>
<person name="Fujiwara Y."/>
<person name="Matsushima M."/>
<person name="Mizuno K."/>
<person name="Tokuyama M."/>
<person name="Hirota H."/>
<person name="Muneuchi J."/>
<person name="Higashinakagawa T."/>
<person name="Matsuoka R."/>
</authorList>
<dbReference type="PubMed" id="17603482"/>
<dbReference type="DOI" id="10.1038/ng2078"/>
</citation>
<scope>VARIANTS NS5 LEU-257; ALA-261; SER-261; ALA-263 AND VAL-613</scope>
<scope>CHARACTERIZATION OF VARIANTS NS5 LEU-257; ALA-261; SER-261; ALA-263 AND VAL-613</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] ALA-259 AND HIS-335</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2010" name="Am. J. Med. Genet. A" volume="152" first="2176" last="2184">
<title>Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations.</title>
<authorList>
<person name="Longoni M."/>
<person name="Moncini S."/>
<person name="Cisternino M."/>
<person name="Morella I.M."/>
<person name="Ferraiuolo S."/>
<person name="Russo S."/>
<person name="Mannarino S."/>
<person name="Brazzelli V."/>
<person name="Coi P."/>
<person name="Zippel R."/>
<person name="Venturin M."/>
<person name="Riva P."/>
</authorList>
<dbReference type="PubMed" id="20683980"/>
<dbReference type="DOI" id="10.1002/ajmg.a.33564"/>
</citation>
<scope>VARIANT NS5 SER-261</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2014" name="Nat. Genet." volume="46" first="635" last="639">
<title>RAF1 mutations in childhood-onset dilated cardiomyopathy.</title>
<authorList>
<person name="Dhandapany P.S."/>
<person name="Razzaque M.A."/>
<person name="Muthusami U."/>
<person name="Kunnoth S."/>
<person name="Edwards J.J."/>
<person name="Mulero-Navarro S."/>
<person name="Riess I."/>
<person name="Pardo S."/>
<person name="Sheng J."/>
<person name="Rani D.S."/>
<person name="Rani B."/>
<person name="Govindaraj P."/>
<person name="Flex E."/>
<person name="Yokota T."/>
<person name="Furutani M."/>
<person name="Nishizawa T."/>
<person name="Nakanishi T."/>
<person name="Robbins J."/>
<person name="Limongelli G."/>
<person name="Hajjar R.J."/>
<person name="Lebeche D."/>
<person name="Bahl A."/>
<person name="Khullar M."/>
<person name="Rathinavel A."/>
<person name="Sadler K.C."/>
<person name="Tartaglia M."/>
<person name="Matsuoka R."/>
<person name="Thangaraj K."/>
<person name="Gelb B.D."/>
</authorList>
<dbReference type="PubMed" id="24777450"/>
<dbReference type="DOI" id="10.1038/ng.2963"/>
</citation>
<scope>INVOLVEMENT IN CMD1NN</scope>
<scope>VARIANTS CMD1NN THR-237; ALA-310; ALA-332; PRO-603; ARG-626 AND MET-641</scope>
<scope>CHARACTERIZATION OF VARIANTS CMD1NN THR-237; ALA-310; ALA-332; PRO-603; ARG-626 AND MET-641</scope>
</reference>
<comment type="function">
<text evidence="15 17 24 25 26 31 32 47">Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text>Binds 2 Zn(2+) ions per subunit.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="13 14 16 18 21 31 36 39">Regulation is a highly complex process involving membrane recruitment, protein-protein interactions, dimerization, and phosphorylation/dephosphorylation events. Ras-GTP recruits RAF1 to the membrane, thereby promoting its activation. The inactive conformation of RAF1 is maintained by autoinhibitory interactions occurring between the N-terminal regulatory and the C-terminal catalytic domains and by the binding of a 14-3-3 protein that contacts two phosphorylation sites, Ser-259 and Ser-621. Upon mitogenic stimulation, Ras and PPP2R1A cooperate to release autoinhibition and the subsequent phosphorylation of activating sites: Ser-338, Tyr-341, Thr-491, and Ser-494, yields a fully active kinase. Through a negative feedback mechanism involving MAPK1/ERK2, RAF1 is phosphorylated on Ser-29, Ser-43, Ser-289, Ser-296, Ser-301 and Ser-642 by MAPK1/ERK2, which yields an inactive, desensitized kinase. The signaling-competent conformation of RAF1 is finally re-established by the coordinated action of PIN1, a prolyl isomerase that converts pSer and pThr residues from the cis to the trans conformation, which is preferentially recognized and dephosphorylated by PPP2R1A. Activated by homodimerization and heterodimerization (with BRAF). Also regulated through association with other proteins such as KSR2, CNKSR1/CNK1, PEBP1/RKIP, PHB/prohibitin and SPRY4. PEBP1/RKIP acts by dissociating RAF1 from its substrates MAP2K1/MEK1 and MAP2K2/MEK2. PHB/prohibitin facilitates the displacement of 14-3-3 from RAF1 by activated Ras, thereby promoting cell membrane localization and phosphorylation of RAF1 at the activating Ser-338. SPRY4 inhibits Ras-independent, but not Ras-dependent, activation of RAF1. CNKSR1/CNK1 regulates Src-mediated RAF1 activation.</text>
</comment>
<comment type="subunit">
<text evidence="8 9 13 14 15 17 18 20 21 24 25 26 27 29 30 36 39 41 42 43 47">Monomer. Homodimer. Heterodimerizes with BRAF and this heterodimer possesses a highly increased kinase activity compared to the respective homodimers or monomers (PubMed:16508002). Heterodimerization is mitogen-regulated and enhanced by 14-3-3 proteins (PubMed:16508002). MAPK1/ERK2 activation can induce a negative feedback that promotes the dissociation of the heterodimer (PubMed:16508002). Forms a multiprotein complex with Ras (M-Ras/MRAS), SHOC2 and protein phosphatase 1 (PPP1CA, PPP1CB and PPP1CC) (PubMed:16630891). Interacts with Ras proteins; the interaction is antagonized by RIN1 (PubMed:11784866). Weakly interacts with RIT1. Interacts (via N-terminus) with RGS14 (via RBD domains); the interaction mediates the formation of a ternary complex with BRAF, a ternary complex inhibited by GNAI1 (By similarity). Interacts with STK3/MST2; the interaction inhibits its pro-apoptotic activity (PubMed:15618521). Interacts (when phosphorylated at Ser-259) with YWHAZ (unphosphorylated at 'Thr-232') (PubMed:9360956). Interacts with MAP2K1/MEK1 and MAP2K2/MEK2 (By similarity). Interacts with MAP3K5/ASF1 (via N-terminus) and this interaction inhibits the proapoptotic function of MAP3K5/ASK1 (PubMed:11427728). Interacts with PAK1 (via kinase domain) (PubMed:11733498). The phosphorylated form interacts with PIN1 (By similarity). The Ser-338 and Ser-339 phosphorylated form (by PAK1) interacts with BCL2 (PubMed:15849194). Interacts with PEBP1/RKIP and this interaction is enhanced if RAF1 is phosphorylated on residues Ser-338, Ser-339, Tyr-340 and Tyr-341 (PubMed:18294816). Interacts with ADCY2, ADCY5, ADCY6, DGKH, RCAN1/DSCR1, PPP1R12A, PKB/AKT1, PPP2CA, PPP2R1B, SPRY2, SPRY4, CNKSR1/CNK1, KSR2 and PHB/prohibitin (PubMed:10801873, PubMed:11719507, PubMed:12717443, PubMed:15385642, PubMed:15935327, PubMed:19710016, PubMed:10576742). Interacts with ROCK2 (By similarity). In its active form, interacts with PRMT5 (PubMed:21917714). Interacts with FAM83B; displaces 14-3-3 proteins from RAF1 and activates RAF1 (PubMed:22886302). Interacts with PDE8A; the interaction promotes RAF1 activity (PubMed:23509299).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-365996"/>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-296087">
<id>P31749</id>
<label>AKT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-700771">
<id>Q92934</id>
<label>BAD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-365980">
<id>P15056</id>
<label>BRAF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>55</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-356673">
<id>P49368</id>
<label>CCT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-747671">
<id>P30304</id>
<label>CDC25A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-536811">
<id>P31327</id>
<label>CPS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-350145">
<id>P01112</id>
<label>HRAS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-354921">
<id>P11021</id>
<label>HSPA5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-367427">
<id>P01116-2</id>
<label>KRAS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-644267">
<id>P32883</id>
<label>Kras</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-642911">
<id>P28301</id>
<label>Lox</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-492564">
<id>Q02750</id>
<label>MAP2K1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>35</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-1056930">
<id>P36507</id>
<label>MAP2K2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-9549291">
<id>Q9ESN9-2</id>
<label>Mapk8ip3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-5278441">
<id>Q12968</id>
<label>NFATC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-721993">
<id>P01111</id>
<label>NRAS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-2548993">
<id>P03495</id>
<label>NS</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-7016711">
<id>O39474</id>
<label>NS5A</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-536879">
<id>O43482</id>
<label>OIP5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-1045887">
<id>Q13177</id>
<label>PAK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-15654365">
<id>Q6TCH7</id>
<label>PAQR3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-641237">
<id>P09619</id>
<label>PDGFRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-716384">
<id>P30086</id>
<label>PEBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-8563667">
<id>Q96S96</id>
<label>PEBP4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-353408">
<id>P14618</id>
<label>PKM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-491414">
<id>P62834</id>
<label>RAP1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-14838">
<id>P01120</id>
<label>RAS2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-491274">
<id>P06400</id>
<label>RB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-1541912">
<id>P53805-2</id>
<label>RCAN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-476295">
<id>P31947</id>
<label>SFN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-992580">
<id>Q13188</id>
<label>STK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-355175">
<id>Q3ZCQ8</id>
<label>TIMM50</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-359815">
<id>P31946</id>
<label>YWHAB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>18</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-356498">
<id>P62258</id>
<label>YWHAE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-306940">
<id>Q04917</id>
<label>YWHAH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-359854">
<id>P27348</id>
<label>YWHAQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365996"/>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Mitochondrion</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Colocalizes with RGS14 and BRAF in both the cytoplasm and membranes. Phosphorylation at Ser-259 impairs its membrane accumulation. Recruited to the cell membrane by the active Ras protein. Phosphorylation at Ser-338 and Ser-339 by PAK1 is required for its mitochondrial localization. Retinoic acid-induced Ser-621 phosphorylated form of RAF1 is predominantly localized at the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P04049-1</id>
<name>1</name>
<name>6C</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P04049-2</id>
<name>2</name>
<name>1A</name>
<sequence type="described" ref="VSP_034649"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="38">In skeletal muscle, isoform 1 is more abundant than isoform 2.</text>
</comment>
<comment type="PTM">
<text evidence="13 14 16 18 19 23 26 28 30 31 37 41 45 46 48">Phosphorylation at Thr-269, Ser-338, Tyr-341, Thr-491 and Ser-494 results in its activation. Phosphorylation at Ser-29, Ser-43, Ser-289, Ser-296, Ser-301 and Ser-642 by MAPK1/ERK2 results in its inactivation. Phosphorylation at Ser-259 induces the interaction with YWHAZ and inactivates kinase activity. Dephosphorylation of Ser-259 by the complex containing protein phosphatase 1, SHOC2 and M-Ras/MRAS relieves inactivation, leading to stimulate RAF1 activity. Phosphorylation at Ser-338 by PAK1 and PAK5 and Ser-339 by PAK1 is required for its mitochondrial localization. Phosphorylation at Ser-621 in response to growth factor treatment stabilizes the protein, possibly by preventing proteasomal degradation. Phosphorylation at Ser-289, Ser-296, Ser-301, Ser-338 and Ser-621 are somehow linked to the methylation potential of cells. Treatment of cells with HGF in the presence of the methylation inhibitor 5'-methylthioadenosine (MTA) results in increased phosphorylation at Ser-338 and Ser-621 and decreased phosphorylation at Ser-296, Ser-301 and Ser-338. Dephosphorylation at Ser-338 by PPP5C results in a activity decrease.</text>
</comment>
<comment type="PTM">
<text evidence="41">Methylated at Arg-563 in response to EGF treatment. This modification leads to destabilization of the protein, possibly through proteasomal degradation.</text>
</comment>
<comment type="disease" evidence="34 35 40">
<disease id="DI-02075">
<name>Noonan syndrome 5</name>
<acronym>NS5</acronym>
<description>A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells.</description>
<dbReference type="MIM" id="611553"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="35">
<disease id="DI-01889">
<name>LEOPARD syndrome 2</name>
<acronym>LPRD2</acronym>
<description>A disorder characterized by lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and sensorineural deafness.</description>
<dbReference type="MIM" id="611554"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="44">
<disease id="DI-04172">
<name>Cardiomyopathy, dilated 1NN</name>
<acronym>CMD1NN</acronym>
<description>A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.</description>
<dbReference type="MIM" id="615916"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="50">Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/raf1/"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/RAF1ID42032ch3p25.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="X03484">
<property type="protein sequence ID" value="CAA27204.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY271661">
<property type="protein sequence ID" value="AAP03432.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312248">
<property type="protein sequence ID" value="BAG35180.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU332868">
<property type="protein sequence ID" value="ABY87557.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471055">
<property type="protein sequence ID" value="EAW64134.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC018119">
<property type="protein sequence ID" value="AAH18119.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L00212">
<property type="protein sequence ID" value="AAA60247.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00206">
<property type="protein sequence ID" value="AAA60247.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00207">
<property type="protein sequence ID" value="AAA60247.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00208">
<property type="protein sequence ID" value="AAA60247.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00209">
<property type="protein sequence ID" value="AAA60247.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00210">
<property type="protein sequence ID" value="AAA60247.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00211">
<property type="protein sequence ID" value="AAA60247.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00213">
<property type="protein sequence ID" value="AAA60247.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M11376">
<property type="protein sequence ID" value="AAA60247.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X54851">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2612.1">
<molecule id="P04049-1"/>
</dbReference>
<dbReference type="PIR" id="A00637">
<property type="entry name" value="TVHUF6"/>
</dbReference>
<dbReference type="PIR" id="S60341">
<property type="entry name" value="S60341"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002871.1">
<molecule id="P04049-1"/>
<property type="nucleotide sequence ID" value="NM_002880.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005265412.1">
<property type="nucleotide sequence ID" value="XM_005265355.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011532276.1">
<molecule id="P04049-1"/>
<property type="nucleotide sequence ID" value="XM_011533974.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.159130"/>
<dbReference type="PDB" id="1C1Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="B=55-131"/>
</dbReference>
<dbReference type="PDB" id="1FAQ">
<property type="method" value="NMR"/>
<property type="chains" value="A=136-187"/>
</dbReference>
<dbReference type="PDB" id="1FAR">
<property type="method" value="NMR"/>
<property type="chains" value="A=136-187"/>
</dbReference>
<dbReference type="PDB" id="1GUA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B=51-131"/>
</dbReference>
<dbReference type="PDB" id="1RFA">
<property type="method" value="NMR"/>
<property type="chains" value="A=55-132"/>
</dbReference>
<dbReference type="PDB" id="3CU8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="P/Q=256-264"/>
</dbReference>
<dbReference type="PDB" id="3IQJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.15"/>
<property type="chains" value="P=255-264"/>
</dbReference>
<dbReference type="PDB" id="3IQU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.05"/>
<property type="chains" value="P=255-260"/>
</dbReference>
<dbReference type="PDB" id="3IQV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.20"/>
<property type="chains" value="P=255-260"/>
</dbReference>
<dbReference type="PDB" id="3KUC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="B=51-131"/>
</dbReference>
<dbReference type="PDB" id="3KUD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="B=51-131"/>
</dbReference>
<dbReference type="PDB" id="3NKX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="P/Q=255-264"/>
</dbReference>
<dbReference type="PDB" id="3O8I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B=255-264"/>
</dbReference>
<dbReference type="PDB" id="3OMV">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="A/B=323-618"/>
</dbReference>
<dbReference type="PDB" id="4FJ3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="P=229-264"/>
</dbReference>
<dbReference type="PDB" id="4G0N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="B=54-131"/>
</dbReference>
<dbReference type="PDB" id="4G3X">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="B=55-131"/>
</dbReference>
<dbReference type="PDB" id="4IEA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="P=618-625"/>
</dbReference>
<dbReference type="PDB" id="4IHL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="P=229-264"/>
</dbReference>
<dbReference type="PDBsum" id="1C1Y"/>
<dbReference type="PDBsum" id="1FAQ"/>
<dbReference type="PDBsum" id="1FAR"/>
<dbReference type="PDBsum" id="1GUA"/>
<dbReference type="PDBsum" id="1RFA"/>
<dbReference type="PDBsum" id="3CU8"/>
<dbReference type="PDBsum" id="3IQJ"/>
<dbReference type="PDBsum" id="3IQU"/>
<dbReference type="PDBsum" id="3IQV"/>
<dbReference type="PDBsum" id="3KUC"/>
<dbReference type="PDBsum" id="3KUD"/>
<dbReference type="PDBsum" id="3NKX"/>
<dbReference type="PDBsum" id="3O8I"/>
<dbReference type="PDBsum" id="3OMV"/>
<dbReference type="PDBsum" id="4FJ3"/>
<dbReference type="PDBsum" id="4G0N"/>
<dbReference type="PDBsum" id="4G3X"/>
<dbReference type="PDBsum" id="4IEA"/>
<dbReference type="PDBsum" id="4IHL"/>
<dbReference type="DisProt" id="DP00171"/>
<dbReference type="ProteinModelPortal" id="P04049"/>
<dbReference type="SMR" id="P04049"/>
<dbReference type="BioGrid" id="111831">
<property type="interactions" value="174"/>
</dbReference>
<dbReference type="CORUM" id="P04049"/>
<dbReference type="DIP" id="DIP-1048N"/>
<dbReference type="IntAct" id="P04049">
<property type="interactions" value="120"/>
</dbReference>
<dbReference type="MINT" id="MINT-86694"/>
<dbReference type="STRING" id="9606.ENSP00000251849"/>
<dbReference type="BindingDB" id="P04049"/>
<dbReference type="ChEMBL" id="CHEMBL1906"/>
<dbReference type="DrugBank" id="DB08912">
<property type="generic name" value="Dabrafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05268">
<property type="generic name" value="iCo-007"/>
</dbReference>
<dbReference type="DrugBank" id="DB04973">
<property type="generic name" value="LErafAON"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00398">
<property type="generic name" value="Sorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05190">
<property type="generic name" value="XL281"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2184"/>
<dbReference type="iPTMnet" id="P04049"/>
<dbReference type="PhosphoSitePlus" id="P04049"/>
<dbReference type="BioMuta" id="RAF1"/>
<dbReference type="DMDM" id="125651"/>
<dbReference type="EPD" id="P04049"/>
<dbReference type="MaxQB" id="P04049"/>
<dbReference type="PaxDb" id="P04049"/>
<dbReference type="PeptideAtlas" id="P04049"/>
<dbReference type="PRIDE" id="P04049"/>
<dbReference type="DNASU" id="5894"/>
<dbReference type="Ensembl" id="ENST00000251849">
<molecule id="P04049-1"/>
<property type="protein sequence ID" value="ENSP00000251849"/>
<property type="gene ID" value="ENSG00000132155"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000442415">
<molecule id="P04049-2"/>
<property type="protein sequence ID" value="ENSP00000401888"/>
<property type="gene ID" value="ENSG00000132155"/>
</dbReference>
<dbReference type="GeneID" id="5894"/>
<dbReference type="KEGG" id="hsa:5894"/>
<dbReference type="UCSC" id="uc003bxf.5">
<molecule id="P04049-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5894"/>
<dbReference type="DisGeNET" id="5894"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000132155.11"/>
<dbReference type="GeneCards" id="RAF1"/>
<dbReference type="GeneReviews" id="RAF1"/>
<dbReference type="HGNC" id="HGNC:9829">
<property type="gene designation" value="RAF1"/>
</dbReference>
<dbReference type="HPA" id="CAB019291"/>
<dbReference type="HPA" id="HPA002640"/>
<dbReference type="MalaCards" id="RAF1"/>
<dbReference type="MIM" id="164760">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="611553">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="611554">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="615916">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04049"/>
<dbReference type="OpenTargets" id="ENSG00000132155"/>
<dbReference type="Orphanet" id="154">
<property type="disease" value="Familial isolated dilated cardiomyopathy"/>
</dbReference>
<dbReference type="Orphanet" id="500">
<property type="disease" value="LEOPARD syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="648">
<property type="disease" value="Noonan syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="251612">
<property type="disease" value="Pilocytic astrocytoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA34183"/>
<dbReference type="eggNOG" id="KOG0193">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410Y4UP">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00900000140880"/>
<dbReference type="HOGENOM" id="HOG000252972"/>
<dbReference type="HOVERGEN" id="HBG001886"/>
<dbReference type="InParanoid" id="P04049"/>
<dbReference type="KO" id="K04366"/>
<dbReference type="OMA" id="HQFIRKT"/>
<dbReference type="OrthoDB" id="EOG091G09SB"/>
<dbReference type="PhylomeDB" id="P04049"/>
<dbReference type="TreeFam" id="TF317006"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2672351">
<property type="pathway name" value="Stimuli-sensing channels"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-392517">
<property type="pathway name" value="Rap1 signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-430116">
<property type="pathway name" value="GP1b-IX-V activation signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-442742">
<property type="pathway name" value="CREB phosphorylation through the activation of Ras"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5621575">
<property type="pathway name" value="CD209 (DC-SIGN) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673000">
<property type="pathway name" value="RAF activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674135">
<property type="pathway name" value="MAP2K and MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674499">
<property type="pathway name" value="Negative feedback regulation of MAPK pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5675221">
<property type="pathway name" value="Negative regulation of MAPK pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802946">
<property type="pathway name" value="Signaling by moderate kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802948">
<property type="pathway name" value="Signaling by high-kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802949">
<property type="pathway name" value="Signaling by RAS mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802952">
<property type="pathway name" value="Signaling by BRAF and RAF fusions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802955">
<property type="pathway name" value="Paradoxical activation of RAF signaling by kinase inactive BRAF"/>
</dbReference>
<dbReference type="SignaLink" id="P04049"/>
<dbReference type="SIGNOR" id="P04049"/>
<dbReference type="ChiTaRS" id="RAF1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P04049"/>
<dbReference type="GeneWiki" id="C-Raf"/>
<dbReference type="GenomeRNAi" id="5894"/>
<dbReference type="PMAP-CutDB" id="P04049"/>
<dbReference type="PRO" id="PR:P04049"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000132155"/>
<dbReference type="CleanEx" id="HS_RAF1"/>
<dbReference type="ExpressionAtlas" id="P04049">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P04049">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005741">
<property type="term" value="C:mitochondrial outer membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031143">
<property type="term" value="C:pseudopodium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004709">
<property type="term" value="F:MAP kinase kinase kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031434">
<property type="term" value="F:mitogen-activated protein kinase kinase binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007190">
<property type="term" value="P:activation of adenylate cyclase activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000186">
<property type="term" value="P:activation of MAPKK activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071550">
<property type="term" value="P:death-inducing signaling complex assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060324">
<property type="term" value="P:face development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035773">
<property type="term" value="P:insulin secretion involved in cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045104">
<property type="term" value="P:intermediate filament cytoskeleton organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034220">
<property type="term" value="P:ion transmembrane transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007275">
<property type="term" value="P:multicellular organism development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043154">
<property type="term" value="P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902042">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031333">
<property type="term" value="P:negative regulation of protein complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009968">
<property type="term" value="P:negative regulation of signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048011">
<property type="term" value="P:neurotrophin TRK receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045595">
<property type="term" value="P:regulation of cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000145">
<property type="term" value="P:regulation of cell motility"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035023">
<property type="term" value="P:regulation of Rho protein signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035994">
<property type="term" value="P:response to muscle stretch"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0035019">
<property type="term" value="P:somatic stem cell population maintenance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048538">
<property type="term" value="P:thymus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030878">
<property type="term" value="P:thyroid gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00029">
<property type="entry name" value="C1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR020454">
<property type="entry name" value="DAG/PE-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR002219">
<property type="entry name" value="PE/DAG-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR003116">
<property type="entry name" value="RBD_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR029071">
<property type="entry name" value="Ubiquitin-like_domsf"/>
</dbReference>
<dbReference type="Pfam" id="PF00130">
<property type="entry name" value="C1_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02196">
<property type="entry name" value="RBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00008">
<property type="entry name" value="DAGPEDOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00109">
<property type="entry name" value="C1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00455">
<property type="entry name" value="RBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54236">
<property type="entry name" value="SSF54236"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50898">
<property type="entry name" value="RBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00479">
<property type="entry name" value="ZF_DAG_PE_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50081">
<property type="entry name" value="ZF_DAG_PE_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0122">Cardiomyopathy</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0209">Deafness</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="RAF proto-oncogene serine/threonine-protein kinase" id="PRO_0000086596">
<location>
<begin position="1"/>
<end position="648"/>
</location>
</feature>
<feature type="domain" description="RBD" evidence="12">
<location>
<begin position="56"/>
<end position="131"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="10">
<location>
<begin position="349"/>
<end position="609"/>
</location>
</feature>
<feature type="zinc finger region" description="Phorbol-ester/DAG-type" evidence="11">
<location>
<begin position="138"/>
<end position="184"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="10">
<location>
<begin position="355"/>
<end position="363"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PEBP1/RKIP">
<location>
<begin position="331"/>
<end position="349"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor">
<location>
<position position="468"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="139"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="152"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="155"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="165"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="168"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="173"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2">
<location>
<position position="176"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1">
<location>
<position position="184"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="10">
<location>
<position position="375"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK1" evidence="9">
<location>
<position position="29"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA and MAPK1" evidence="46">
<location>
<position position="43"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="252"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA, PKC and PKB/AKT1" evidence="13 14 19 23 30 31 46">
<location>
<position position="259"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="46">
<location>
<position position="268"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKA" evidence="45">
<location>
<position position="269"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK1" evidence="6 41">
<location>
<position position="289"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="296"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK1" evidence="6 7 41">
<location>
<position position="301"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PAK1, PAK2, PAK3 and PAK5" evidence="18 26 31 37 41">
<location>
<position position="338"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PAK1, PAK2 and PAK3" evidence="26">
<location>
<position position="339"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC" evidence="31">
<location>
<position position="340"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC" evidence="31">
<location>
<position position="341"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="28">
<location>
<position position="471"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="16">
<location>
<position position="491"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="494"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC" evidence="46">
<location>
<position position="499"/>
</location>
</feature>
<feature type="modified residue" description="Symmetric dimethylarginine; by PRMT5" evidence="41">
<location>
<position position="563"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 31 41 46">
<location>
<position position="621"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK1" evidence="5 7">
<location>
<position position="642"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_034649" evidence="50">
<original>E</original>
<variation>ENNNLSASPRAWSRRFCLRGR</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1NN; shows a mild increase in kinase activity; dbSNP:rs587777588." id="VAR_071844" evidence="44">
<original>A</original>
<variation>T</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5; dbSNP:rs397516826." id="VAR_037807" evidence="35">
<original>R</original>
<variation>S</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5 and LPRD2; shows in vitro greater kinase activity and enhanced ERK activation than wild-type; dbSNP:rs80338796." id="VAR_037808" evidence="34 35">
<original>S</original>
<variation>L</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian serous carcinoma sample; somatic mutation; increased ERK activation." id="VAR_041037" evidence="30 33">
<original>S</original>
<variation>A</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5; dbSNP:rs397516827." id="VAR_037809" evidence="35">
<original>S</original>
<variation>F</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In hypertrophic cardiomyopathy; dbSNP:rs869025501." id="VAR_037810" evidence="35">
<original>T</original>
<variation>I</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5." id="VAR_037811" evidence="35">
<original>T</original>
<variation>R</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs121434594." id="VAR_037812" evidence="34">
<original>P</original>
<variation>A</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5; shows greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs397516828." id="VAR_037813" evidence="35">
<original>P</original>
<variation>L</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs121434594." id="VAR_037814" evidence="34 35 40">
<original>P</original>
<variation>S</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type." id="VAR_037815" evidence="34">
<original>V</original>
<variation>A</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5746220." id="VAR_018840" evidence="22 49">
<original>P</original>
<variation>L</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1NN; shows a mild increase in kinase activity; dbSNP:rs778155315." id="VAR_071845" evidence="44">
<original>T</original>
<variation>A</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1NN; shows a mild increase in kinase activity; dbSNP:rs1057403865." id="VAR_071846" evidence="44">
<original>P</original>
<variation>A</variation>
<location>
<position position="332"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma sample; somatic mutation." id="VAR_041038" evidence="33">
<original>Q</original>
<variation>H</variation>
<location>
<position position="335"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5; dbSNP:rs397516815." id="VAR_037816" evidence="35">
<original>D</original>
<variation>G</variation>
<location>
<position position="486"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5; has reduced or absent kinase activity; dbSNP:rs80338798." id="VAR_037817" evidence="35">
<original>D</original>
<variation>N</variation>
<location>
<position position="486"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5; has reduced or absent kinase activity; dbSNP:rs80338799." id="VAR_037818" evidence="35">
<original>T</original>
<variation>I</variation>
<location>
<position position="491"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5; dbSNP:rs80338799." id="VAR_037819" evidence="35">
<original>T</original>
<variation>R</variation>
<location>
<position position="491"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1NN; shows impaired kinase activity and reduced MAPK3 activation with this mutation; dbSNP:rs587777586." id="VAR_071847" evidence="44">
<original>L</original>
<variation>P</variation>
<location>
<position position="603"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5." id="VAR_037820" evidence="35">
<original>S</original>
<variation>T</variation>
<location>
<position position="612"/>
</location>
</feature>
<feature type="sequence variant" description="In NS5 and LPRD2; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs80338797." id="VAR_037821" evidence="34 35">
<original>L</original>
<variation>V</variation>
<location>
<position position="613"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1NN; shows a mild increase in kinase activity." id="VAR_071848" evidence="44">
<original>H</original>
<variation>R</variation>
<location>
<position position="626"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1NN; shows a mild increase in kinase activity; dbSNP:rs587777587." id="VAR_071849" evidence="44">
<original>T</original>
<variation>M</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced kinase activity; when associated with 340-D-D-341." evidence="31">
<original>SS</original>
<variation>AA</variation>
<location>
<begin position="338"/>
<end position="339"/>
</location>
</feature>
<feature type="mutagenesis site" description="Non-inhibited by PPP5C. Constitutively active and non-inhibited by PPP5C; when associated with 340-D-D-341." evidence="31">
<original>SS</original>
<variation>DE</variation>
<location>
<begin position="338"/>
<end position="339"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutively active and highly phosphorylated on S-338, inhibited by PPP5C. Reduced kinase activity; when associated with 338-A-A-339. Constitutively active and non-inhibited by PPP5C; when associated with 338-D-E-339." evidence="31">
<original>YY</original>
<variation>DD</variation>
<location>
<begin position="340"/>
<end position="341"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased kinase activity but can still be inhibited by PPP5C; when associated with D-494." evidence="31">
<original>T</original>
<variation>D</variation>
<location>
<position position="491"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased kinase activity but can still be inhibited by PPP5C; when associated with D-491." evidence="31">
<original>S</original>
<variation>D</variation>
<location>
<position position="494"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of methylation. Increased stability and catalytic activity in response to EGF treatment." evidence="41">
<original>R</original>
<variation>K</variation>
<location>
<position position="563"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAA60247." ref="6" evidence="50">
<original>F</original>
<variation>L</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAA60247." ref="6" evidence="50">
<original>M</original>
<variation>I</variation>
<location>
<position position="542"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="57"/>
<end position="62"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="63"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="66"/>
<end position="71"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="78"/>
<end position="87"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="88"/>
<end position="90"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="93"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="96"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="103"/>
<end position="105"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="106"/>
<end position="112"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="118"/>
<end position="121"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="125"/>
<end position="130"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="155"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="161"/>
<end position="164"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="166"/>
<end position="169"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="174"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="177"/>
<end position="182"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1C1Y"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FAQ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FAR"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P11345"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q99N57"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00226"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00262"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10576742"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10801873"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11427728"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11447113"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11719507"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11733498"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11756411"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11784866"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12717443"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15047712"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15385642"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15618521"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15849194"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15935327"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16093354"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16508002"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16630891"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16892053"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16924233"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17603482"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17603483"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18294816"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18465753"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1886707"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19710016"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20683980"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21917714"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22886302"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23509299"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24777450"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7477354"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8349614"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9360956"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9823899"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="50" type="ECO:0000305"/>
<sequence length="648" mass="73052" checksum="EF821B5349711BC3" modified="1986-11-01" version="1">
MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRV
FLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAAS
LIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKV
PTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTF
NTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNL
SPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSF
GTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIV
TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL
TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYE
LMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFP
QILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>